Skip to main content
Clinical Trials/JPRN-UMIN000040689
JPRN-UMIN000040689
Completed
未知

Glycemic control among diabetic patients complicated with sarcopenia and frailty. - Glycemic control among diabetic patients complicated with sarcopenia and frailty.

Juntendo University, Juntendo Tokyo Koto Geriatric Medical Center0 sites140 target enrollmentJune 10, 2020

Overview

Phase
未知
Intervention
Not specified
Conditions
diabetes mellitus
Sponsor
Juntendo University, Juntendo Tokyo Koto Geriatric Medical Center
Enrollment
140
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
June 10, 2020
End Date
May 31, 2022
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Juntendo University, Juntendo Tokyo Koto Geriatric Medical Center

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Severe cardio\-pulmonary disease Severe Hypertension Fever Recent pulmonary infarction, Severe liver dysfunction Severe renal dysfunction Severe Orthopedics problems Severe metabolic disease Cardiac pacemaker or elctronic implant Clipping, metal in the body Weight over 200kgs

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Not Applicable
Glycaemic control in patients with type 2 diabetes and colorectal- or breast cancer treated with curative intentType 2 diabetes (T2DM)Breast cancer/borstkankerColorectal cancer/colorectale kankerHypertension/hypertensieDyslipidemia/dyslipidemie
NL-OMON23282Diabetes Kenniscentrum Zwolle156
Not yet recruiting
Not Applicable
Glycemic control of in patient type2 diabetes mellitus comparing between Thammasart insulin protocol and routine care: randomized-controlled trialInhospital hyperglycemiaInsulinDiabetes millitus
TCTR20180316006one90
Completed
Phase 2
To Observe the Average Blood Glucose level in Diabetic PatientsHealth Condition 1: null- Diabetic
CTRI/2018/06/014350ational Institute of Siddha100
Completed
Not Applicable
An observational study to assess degree of diabetes control in terms of glycated haemoglobin, proportion of patients having diabetic complications and future risk of heart disease in diabetic patients receiving antidiabetic medication.Health Condition 1: null- Type 2 Diabetes Mellitus
CTRI/2018/03/012806Shraddha M Pore221
Recruiting
Not Applicable
Improving glycaemic control of patients with type 2 diabetes mellitus (T2DM) through management by a community based, multidisciplinary, integrated primary care / specialist level care service.Type 2 diabetes mellitus (T2DM)Recognised complications of T2DMType 2 diabetes mellitus (T2DM)Recognised complications of T2DMMetabolic and Endocrine - DiabetesPublic Health - Health service research
ACTRN12608000010392Community & Primary Health Services, Queensland Health250